Contraception, also referred to as birth control, is a method to control unwanted pregnancy. It has been used since ancient times; however, effective contraceptive methods have been introduced in 20th century only. Today, the market is filled with number of contraceptive options providing desirable results and efficacy. The global contraceptive market is experiencing a robust growth at a lucrative CAGR. Every year, a greater number of people undergoing contraceptive sterilization can be observed. Also, there is a high demand of male condoms due to their affordability, availability and higher efficiency to prevent pregnancy and exposure to sexually transmitted diseases (STDs).

Female contraception drug products are major boosters for the growth of the global contraceptive market. There is a continually growing population of females using hormonal contraception. Oral pills and IUDs are the widely used methods of contraception among females. The global female contraception drug market would continue to move forward with a healthy growth rate in future.

Regionally, the U.S. is the major market for contraceptives due to its increasing female population of childbearing age, higher concentration of key companies, higher awareness of contraceptives and STDs infections, and increasing consumption of female condoms. Also, the desirable size of a family in the U.S. is of two children which supports the consumption of contraceptives in the region. Europe also holds a notable share in the global contraceptive market. However, its share can drop to some extent in future due to decreasing female population of reproductive ages.

In terms of competition, the global contraceptive market is highly fragmented with a huge number of companies selling generic products. However, the global female contraceptive drug market is dominated by four companies that include Bayer AG, Allergan PLC, Merck & Co. and Teva Pharmaceuticals.

1. Overview

1.1 Contraceptive

2. Global Contraceptive Market

2.1 Contraceptive Market Forecast by Value
2.2 Contraceptive Market by Region
2.3 Female Contraceptive Drug Market Forecast by Value
2.4 Female Contraceptive Drug Market by Region
2.5 Female Contraceptive User Volume Forecast

3. Regional Contraceptive Market

3.1 The U.S
3.1.1 The U.S. Contraceptive Market Forecast by Value
3.1.2 The U.S. Contraceptive Market by Type
3.1.3 The U.S. Female Contraceptive Drug Market Forecast by Value
3.1.4 The U.S. Contraceptive Script Volume Forecast
3.1.5 The U.S. Contraceptive Script Volume by Type
3.1.6 The U.S. Female Contraceptive User Volume Forecast

3.2 Europe
3.2.1 Europe Contraceptive Market Forecast by Value
3.2.2 Europe Female Contraceptive Drug Market Forecast by Value
3.2.3 Europe Contraceptive User Volume Forecast
3.2.4 Europe Contraceptive User by Type

3.3 ROW
3.3.1 ROW Contraceptive Market Forecast by Value

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Increasing Female Population of Reproductive Ages
4.1.2 Growing Disposable Incomes
4.1.3 Increasing Urban Population

4.2 Key Trends
4.2.1 Unmet Need for Family Planning
4.2.2 Pipeline Programs in Development
4.2.3 Increasing Use of Female Condoms
4.2.4 Increasing Trend of Non-Daily Dosing

4.3 Challenges
4.3.1 Decreasing Fertility Rates
4.3.2 Irregularities in Sex Education
4.3.3 Associated Risks

5. Competition

5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players
5.1.3 Global Female Contraceptive Drug Market Share by Company

6. Company Profiles

6.1 Bayer
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 Merck & Co., Inc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 Teva Pharmaceuticals
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 Allergan Plc
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Charts

Types of Contraceptive Methods
Global Contraceptive Market Forecast by Value (2017-2022)
Global Contraceptive Market by Region (2017)
Global Female Contraceptive Drug Market Forecast by Value (2017-2022)
Global Female Contraceptive Drug Market by Region (2017)
Global Female Contraceptive User Volume Forecast (2017-2022)
The U.S. Contraceptive Market Forecast by Value (2017-2022)
The U.S. Contraceptive Market by Type (2017)
The U.S. Female Contraceptive Drug Market Forecast by Value (2017-2022)
The U.S. Contraceptive Script Volume Forecast (2017-2022)
The U.S. Contraceptive Script Volume by Type (2017)
The U.S. Female Contraceptive User Volume Forecast (2017-2022)
Europe Contraceptive Market Forecast by Value (2017-2022)
Europe Female Contraceptive Drug Market Forecast by Value (2017-2022)
Europe Contraceptive User Volume Forecast (2017-2022)
Europe Contraceptive User by Type (2017)
ROW Contraceptive Market Forecast by Value (2017-2022)
The U.S. Female Population Forecast (Age 15-44 years) (2017-2022)
Global GNI per Capita (2013-2017)
Global Urban Population (2017)
Global Fertility Rate (2017)
Global Contraceptive Market- Revenue Comparison (2017)
Market Cap Comparison of Key Players
Global Female Contraceptive Drug Market Share by Company (2017)
Bayer Revenue by Segment (2017)
Bayer Sales and Net Income (2013-2017)
Bayer Research and Development Expenditure (2015-2017)
Merck & Co., Inc. Net Sales by Business Segments (2017)
Merck & Co., Inc. Net Sales and Net Income (2013-2017)
Merck & Co., Inc. Research and Development Expenditures (2015-2017)
Teva Pharmaceuticals Revenue by Segments (2017)
Teva Pharmaceuticals Revenue and Net Income (2013-2017)
Teva Pharmaceuticals Research and Development Expenditures (2015-2017)
Allergan Plc Net Revenues by Business Segments (2017)
Allergan Plc Net Revenues and Net Income (Loss) (2013-2017)
Allergan Plc Research and Development Expenditures (2015-2017)

List of Tables

Number of Women with Unmet Need of Family Planning (in thousands) (2000-2030)
Late-Stage Contraceptive Programs